Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 22 records, 3 pages
Search For: Estrogen Receptor
Global Estrogen Receptor Supply, Demand and Key Producers, 2024-2030
10 Feb 2024
Pharma & Healthcare
The global Estrogen Receptor market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Estrogen Receptor Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Estrogen Receptor market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Estrogen Receptor Beta Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
16 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Estrogen Receptor Beta market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Estrogen Receptor Agonist Market 2024 by Company, Regions, Type and Application, Forecast to 2030
10 Jan 2024
Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Estrogen Receptor Agonist market size was valued at USD 2767.9 million in 2023 and is forecast to a readjusted size of USD 3718.1 million by 2030 with a CAGR of 4.3% during review period.
USD3480.00
Add To Cart
Global Estrogen Receptor Modulators Supply, Demand and Key Producers, 2024-2030
29 Feb 2024
Pharma & Healthcare
The global Estrogen Receptor Modulators market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Estrogen Receptor Modulators Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
10 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Estrogen Receptor Modulators market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Selective Estrogen Receptor Degrader Supply, Demand and Key Producers, 2024-2030
19 Feb 2024
Pharma & Healthcare
Selective Estrogen Receptor Degrader
The global Selective Estrogen Receptor Degrader market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Selective Estrogen Receptor Degrader Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
10 Jan 2024
Pharma & Healthcare
Selective Estrogen Receptor Degrader
According to our (Global Info Research) latest study, the global Selective Estrogen Receptor Degrader market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Selective Estrogen Receptor Modulators Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
16 Oct 2024
Pharma & Healthcare
Selective Estrogen Receptor Modulators
Selective Estrogen Receptor Modulators are a class of compounds that selectively bind to estrogen receptors and exert tissue-specific effects, mimicking or blocking estrogen's actions depending on the target tissue. Unlike estrogen itself, which generally has a uniform effect across various tissues, SERMs can act as estrogen agonists in some tissues while serving as antagonists in others. This selective activity allows SERMs to provide therapeutic benefits such as promoting bone health in osteoporosis or reducing the risk of certain cancers, like breast cancer, by modulating estrogen receptor activity in a targeted manner.
USD3480.00
Add To Cart
Global Selective Estrogen Receptor Modulators Supply, Demand and Key Producers, 2024-2030
16 Oct 2024
Pharma & Healthcare
Selective Estrogen Receptor Modulators
Selective Estrogen Receptor Modulators are a class of compounds that selectively bind to estrogen receptors and exert tissue-specific effects, mimicking or blocking estrogen's actions depending on the target tissue. Unlike estrogen itself, which generally has a uniform effect across various tissues, SERMs can act as estrogen agonists in some tissues while serving as antagonists in others. This selective activity allows SERMs to provide therapeutic benefits such as promoting bone health in osteoporosis or reducing the risk of certain cancers, like breast cancer, by modulating estrogen receptor activity in a targeted manner.
USD4480.00
Add To Cart
- 1
- 2
- 3
Go To Page
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Estrogen Receptor
Total: 22 records, 3 pages
The global Estrogen Receptor market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Estrogen Receptor market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Estrogen Receptor Beta market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Estrogen Receptor Agonist market size was valued at USD 2767.9 million in 2023 and is forecast to a readjusted size of USD 3718.1 million by 2030 with a CAGR of 4.3% during review period.
USD3480.00
Add To Cart
The global Estrogen Receptor Modulators market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Estrogen Receptor Modulators market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
The global Selective Estrogen Receptor Degrader market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Selective Estrogen Receptor Degrader market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Selective Estrogen Receptor Modulators are a class of compounds that selectively bind to estrogen receptors and exert tissue-specific effects, mimicking or blocking estrogen's actions depending on the target tissue. Unlike estrogen itself, which generally has a uniform effect across various tissues, SERMs can act as estrogen agonists in some tissues while serving as antagonists in others. This selective activity allows SERMs to provide therapeutic benefits such as promoting bone health in osteoporosis or reducing the risk of certain cancers, like breast cancer, by modulating estrogen receptor activity in a targeted manner.
USD3480.00
Add To Cart
Selective Estrogen Receptor Modulators are a class of compounds that selectively bind to estrogen receptors and exert tissue-specific effects, mimicking or blocking estrogen's actions depending on the target tissue. Unlike estrogen itself, which generally has a uniform effect across various tissues, SERMs can act as estrogen agonists in some tissues while serving as antagonists in others. This selective activity allows SERMs to provide therapeutic benefits such as promoting bone health in osteoporosis or reducing the risk of certain cancers, like breast cancer, by modulating estrogen receptor activity in a targeted manner.
USD4480.00
Add To Cart
- 1
- 2
- 3
Go To Page
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>